These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 12325162

  • 1. Novel strategies for targeting the dimerization interface of HIV protease with cross-linked interfacial peptides.
    Bowman MJ, Chmielewski J.
    Biopolymers; 2002; 66(2):126-33. PubMed ID: 12325162
    [Abstract] [Full Text] [Related]

  • 2. Sidechain-linked inhibitors of HIV-1 protease dimerization.
    Bowman MJ, Chmielewski J.
    Bioorg Med Chem; 2009 Feb 01; 17(3):967-76. PubMed ID: 18337105
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dimerization inhibitors of HIV-1 protease.
    Boggetto N, Reboud-Ravaux M.
    Biol Chem; 2002 Sep 01; 383(9):1321-4. PubMed ID: 12437124
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Small-molecule dimerization inhibitors of wild-type and mutant HIV protease: a focused library approach.
    Shultz MD, Ham YW, Lee SG, Davis DA, Brown C, Chmielewski J.
    J Am Chem Soc; 2004 Aug 18; 126(32):9886-7. PubMed ID: 15303839
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Triterpenes as potential dimerization inhibitors of HIV-1 protease.
    Quéré L, Wenger T, Schramm HJ.
    Biochem Biophys Res Commun; 1996 Oct 14; 227(2):484-8. PubMed ID: 8967903
    [Abstract] [Full Text] [Related]

  • 9. A folding inhibitor of the HIV-1 protease.
    Broglia RA, Provasi D, Vasile F, Ottolina G, Longhi R, Tiana G.
    Proteins; 2006 Mar 01; 62(4):928-33. PubMed ID: 16385559
    [Abstract] [Full Text] [Related]

  • 10. A unidirectional crosslinking strategy for HIV-1 protease dimerization inhibitors.
    Hwang YS, Chmielewski J.
    Bioorg Med Chem Lett; 2004 Aug 16; 14(16):4297-300. PubMed ID: 15261290
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, and evaluation of conformationally constrained tongs, new inhibitors of HIV-1 protease dimerization.
    Bouras A, Boggetto N, Benatalah Z, de Rosny E, Sicsic S, Reboud-Ravaux M.
    J Med Chem; 1999 Mar 25; 42(6):957-62. PubMed ID: 10090778
    [Abstract] [Full Text] [Related]

  • 12. Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors.
    Böttcher J, Blum A, Dörr S, Heine A, Diederich WE, Klebe G.
    ChemMedChem; 2008 Sep 25; 3(9):1337-44. PubMed ID: 18720485
    [Abstract] [Full Text] [Related]

  • 13. An alternative strategy for inhibiting multidrug-resistant mutants of the dimeric HIV-1 protease by targeting the subunit interface.
    Bannwarth L, Reboud-Ravaux M.
    Biochem Soc Trans; 2007 Jun 25; 35(Pt 3):551-4. PubMed ID: 17511649
    [Abstract] [Full Text] [Related]

  • 14. Comparative studies on inhibitors of HIV protease: a target for drug design.
    Jayaraman S, Shah K.
    In Silico Biol; 2008 Jun 25; 8(5-6):427-47. PubMed ID: 19374129
    [Abstract] [Full Text] [Related]

  • 15. Beta-lactam compounds as apparently uncompetitive inhibitors of HIV-1 protease.
    Sperka T, Pitlik J, Bagossi P, Tözsér J.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3086-90. PubMed ID: 15893929
    [Abstract] [Full Text] [Related]

  • 16. Oximinoarylsulfonamides as potent HIV protease inhibitors.
    Yeung CM, Klein LL, Flentge CA, Randolph JT, Zhao C, Sun M, Dekhtyar T, Stoll VS, Kempf DJ.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2275-8. PubMed ID: 15837308
    [Abstract] [Full Text] [Related]

  • 17. Switching between allosteric and dimerization inhibition of HIV-1 protease.
    Bowman MJ, Byrne S, Chmielewski J.
    Chem Biol; 2005 Apr 02; 12(4):439-44. PubMed ID: 15850980
    [Abstract] [Full Text] [Related]

  • 18. HIV-1 protease folding and the design of drugs which do not create resistance.
    Broglia R, Levy Y, Tiana G.
    Curr Opin Struct Biol; 2008 Feb 02; 18(1):60-6. PubMed ID: 18160276
    [Abstract] [Full Text] [Related]

  • 19. Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties.
    Frecer V, Berti F, Benedetti F, Miertus S.
    J Mol Graph Model; 2008 Oct 02; 27(3):376-87. PubMed ID: 18678515
    [Abstract] [Full Text] [Related]

  • 20. Comparison of inhibitor binding to feline and human immunodeficiency virus proteases: structure-based drug design and the resistance problem.
    Dunn BM, Pennington MW, Frase DC, Nash K.
    Biopolymers; 1999 Oct 02; 51(1):69-77. PubMed ID: 10380354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.